Molecule Information
General Information of the Molecule (ID: Mol04300)
| Name |
Hyaluronan mediated motility receptor (HMMR)
,Homo sapiens
|
||||
|---|---|---|---|---|---|
| Synonyms |
Intracellular hyaluronic acid-binding protein; Receptor for hyaluronan-mediated motility; CD_antigen=CD168
Click to Show/Hide
|
||||
| Molecule Type |
Protein
|
||||
| Gene Name |
HMMR
|
||||
| Gene ID | |||||
| Sequence |
MSFPKAPLKRFNDPSGCAPSPGAYDVKTLEVLKGPVSFQKSQRFKQQKESKQNLNVDKDT
TLPASARKVKSSESKESQKNDKDLKILEKEIRVLLQERGAQDRRIQDLETELEKMEARL N AALREKTSLSANNATLEKQLIELTRTNELLKSKFSENGNQKNLRILSLELMKLRNKRE TK MRGMMAKQEGMEMKLQVTQRSLEESQGKIAQLEGKLVSIEKEKIDEKSETEKLLEYI EEI SCASDQVEKYKLDIAQLEENLKEKNDEILSLKQSLEENIVILSKQVEDLNVKCQLL EKEK EDHVNRNREHNENLNAEMQNLKQKFILEQQEREKLQQKELQIDSLLQQEKELSSS LHQKL CSFQEEMVKEKNLFEEELKQTLDELDKLQQKEEQAERLVKQLEEEAKSRAEELK LLEEKL KGKEAELEKSSAAHTQATLLLQEKYDSMVQSLEDVTAQFESYKALTASEIEDL KLENSSL QEKAAKAGKNAEDVQHQILATESSNQEYVRMLLDLQTKSALKETEIKEITVS FLQKITDL QNQLKQQEEDFRKQLEDEEGRKAEKENTTAELTEEINKWRLLYEELYNKTK PFQLQLDAF EVEKQALLNEHGAAQEQLNKIRDSYAKLLGHQNLKQKIKHVVKLKDENSQ LKSEVSKLRC QLAKKKQSETKLQEELNKVLGIKHFDPSKAFHHESKENFALKTPLKEGN TNCYRAPMECQ ESWK Click to Show/Hide
|
||||
| Function |
Receptor for hyaluronic acid . Involvedin cell motility . When hyaluronan binds to HMMR, thephosphorylation of a number of proteins, including PTK2/FAK1 occurs.May also be involved in cellular transformation and metastasisformation, and in regulating extracellular-regulated kinase activity. May act as a regulator of adipogenisis .{ECO:0000250|UniProtKB:Q00547}.
Click to Show/Hide
|
||||
| Uniprot ID | |||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Disease Class: Breast adenocarcinoma [ICD-11: 2C60.1] | [1] | |||
| Resistant Disease | Breast adenocarcinoma [ICD-11: 2C60.1] | |||
| Resistant Drug | Epirubicin | |||
| Molecule Alteration | Expression | Up-regulation |
||
| Experimental Note | Revealed Based on the Cell Line Data | |||
| Cell Pathway Regulation | RHAMM signaling pathway | Regulation | N.A. | |
| In Vitro Model | 231-EPIR cells | Breast | Homo sapiens (Human) | N.A. |
| M-EPIR cells | Breast | Homo sapiens (Human) | N.A. | |
| Experiment for Molecule Alteration |
RT-PCR | |||
| Experiment for Drug Resistance |
CCK8 assay | |||
| Mechanism Description | We demonstrated that RHAMM immensely contributes to breast cancer chemoresistance by several mechanisms: promoting proliferation and migration, enrichment of breast cancer stemness, and induction of EMT. Also, we found that RHAMM served as a potent prognostic factor in breast cancer patients, especially in those who received chemotherapy. | |||
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Yu.
